China Traditional Chinese Medicine Holdings Co. Ltd.

As of December 31, 2025, China Traditional Chinese Medicine Holdings Co. Ltd. carries a market capitalization of 10.52B, placing it among publicly traded companies globally. Its enterprise value stands at 10.53B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

China Traditional Chinese Medicine Holdings Co. Ltd.'s next confirmed earnings release is scheduled for March 19, 2027.

As of December 31, 2025, China Traditional Chinese Medicine Holdings Co. Ltd. has 5.04B shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, China Traditional Chinese Medicine Holdings Co. Ltd. maintains a current ratio of 2.29, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, China Traditional Chinese Medicine Holdings Co. Ltd.'s stock has declined approximately 54.76% over the past 52 weeks. The 50-day moving average sits at 1.29, while the 200-day moving average is 1.64.

As of December 31, 2025, China Traditional Chinese Medicine Holdings Co. Ltd. holds 5.62B in cash and equivalents against 2.78B in total debt, resulting in a net debt position of -1.69B. Total book value stands at 22.78B, with working capital of 11.10B providing operational flexibility.

China Traditional Chinese Medicine Holdings Co. Ltd.'s most recent stock split took place on January 13, 1994.